| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 10 |
| GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: A4HKV2
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 30 | 32 | PF00675 | 0.341 |
| CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.346 |
| CLV_PCSK_SKI1_1 | 31 | 35 | PF00082 | 0.265 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.461 |
| DOC_CKS1_1 | 78 | 83 | PF01111 | 0.409 |
| DOC_MAPK_gen_1 | 29 | 35 | PF00069 | 0.534 |
| DOC_PP2B_LxvP_1 | 83 | 86 | PF13499 | 0.415 |
| DOC_USP7_MATH_1 | 18 | 22 | PF00917 | 0.297 |
| DOC_USP7_MATH_1 | 65 | 69 | PF00917 | 0.294 |
| DOC_WW_Pin1_4 | 77 | 82 | PF00397 | 0.379 |
| LIG_FHA_1 | 34 | 40 | PF00498 | 0.357 |
| LIG_FHA_1 | 78 | 84 | PF00498 | 0.337 |
| LIG_PCNA_PIPBox_1 | 89 | 98 | PF02747 | 0.197 |
| LIG_PTB_Apo_2 | 87 | 94 | PF02174 | 0.410 |
| LIG_PTB_Phospho_1 | 87 | 93 | PF10480 | 0.410 |
| LIG_SH2_STAP1 | 112 | 116 | PF00017 | 0.615 |
| LIG_SH2_STAP1 | 53 | 57 | PF00017 | 0.355 |
| LIG_SH2_STAT3 | 103 | 106 | PF00017 | 0.418 |
| LIG_SH2_STAT5 | 3 | 6 | PF00017 | 0.372 |
| LIG_SH2_STAT5 | 73 | 76 | PF00017 | 0.345 |
| LIG_SH3_3 | 46 | 52 | PF00018 | 0.421 |
| MOD_GlcNHglycan | 43 | 46 | PF01048 | 0.336 |
| MOD_GlcNHglycan | 67 | 70 | PF01048 | 0.532 |
| MOD_GSK3_1 | 84 | 91 | PF00069 | 0.308 |
| MOD_N-GLC_2 | 17 | 19 | PF02516 | 0.410 |
| MOD_N-GLC_2 | 40 | 42 | PF02516 | 0.494 |
| MOD_NEK2_1 | 33 | 38 | PF00069 | 0.283 |
| MOD_NEK2_1 | 88 | 93 | PF00069 | 0.339 |
| MOD_Plk_4 | 84 | 90 | PF00069 | 0.303 |
| MOD_ProDKin_1 | 77 | 83 | PF00069 | 0.378 |
| TRG_ENDOCYTIC_2 | 3 | 6 | PF00928 | 0.408 |
| TRG_ER_diArg_1 | 29 | 31 | PF00400 | 0.547 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P8N3 | Leptomonas seymouri | 79% | 100% |
| A0A0S4IXI5 | Bodo saltans | 37% | 87% |
| A0A1X0NRS6 | Trypanosomatidae | 46% | 100% |
| A0A3S7X608 | Leishmania donovani | 94% | 100% |
| A4I8D1 | Leishmania infantum | 94% | 100% |
| D0AAU2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 99% |
| E9B390 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
| Q4Q4W5 | Leishmania major | 92% | 100% |
| V5B5T9 | Trypanosoma cruzi | 48% | 100% |